{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T07:04:58Z","timestamp":1764745498815,"version":"3.46.0"},"reference-count":7,"publisher":"Touch Medical Media, Ltd.","issue":"2","license":[{"start":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T00:00:00Z","timestamp":1518739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"This article is published under the Creative Commons Attribution Non-commercial License."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"abstract":"<p\/>","DOI":"10.17925\/ee.2019.15.2.92","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T08:17:08Z","timestamp":1566807428000},"page":"92","source":"Crossref","is-referenced-by-count":2,"title":["Metastatic MEN1 Syndrome Treated with Lutetium-177 \u2013 A Case Report"],"prefix":"10.17925","volume":"15","author":[{"given":"Emre","family":"Gezer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berrin","family":"\u00c7etinarslan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep","family":"Cant\u00fcrk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130lhan","family":"Tarkun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"S\u00f6zen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alev","family":"Selek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Endocrinology and Metabolism, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7274","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Pieterman CRC, Vriens MR, Dreijerink KMA, et al. Care for patients with multiple endocrine neoplasia type 1: The current evidence base.\n                      Fam Cancer\n                      . 2011;10:157\u201371.","DOI":"10.1007\/s10689-010-9398-6"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Ito T, Igarashi H, Uehara H, et al. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: A prospective study: Comparison of 106 men1\/zollinger-ellison syndrome patients with 1613 literature men1 patients with or without pancreatic endocrine tumors.\n                      Medicine (Baltimore)\n                      . 2013;92:135\u201381.","DOI":"10.1097\/MD.0b013e3182954af1"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Strosberg J, El-Haddad G, Wolin E, et al. Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors.\n                      N Engl J Med\n                      . 2017;376:125\u201335.","DOI":"10.1056\/NEJMoa1607427"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Hicks RJ, Kwekkeboom DJ, Krenning E, et al. ENETS consensus guidelines for the standards of care in neuroendocrine neoplasms: peptide receptor radionuclide therapy with radiolabelled somatostatin analogues.\n                      Neuroendocrinology\n                      . 2017;105:295\u2013309.","DOI":"10.1159\/000475526"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Chakedis J, Beal EW, Lopez-Aguiar AG, et al. Surgery provides long-term survival in patients with metastatic neuroendocrine tumors undergoing resection for non-hormonal symptoms.\n                      J Gastrointest Surg\n                      . 2019;23:122\u201334.","DOI":"10.1007\/s11605-018-3986-4"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Brabander T, Van Der Zwan WA, Teunissen JJM, et al. Long-term efficacy, survival, and safety of [177Lu-DOTA0,Tyr3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors.\n                      Clin Cancer Res\n                      . 2017;23:4617\u201324.","DOI":"10.1158\/1078-0432.CCR-16-2743"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Khan S, Krenning EP, van Essen M, Kam BL, et al. Quality of life in 265 patients with gastroenteropancreatic or bronchial neuroendocrine tumors treated with [177Lu-DOTA0,Tyr3]octreotate.\n                      J Nucl Med\n                      . 2011;52:1361\u20138.","DOI":"10.2967\/jnumed.111.087932"}],"container-title":["European Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/touchendocrinology.com\/endocrine-oncology\/journal-articles\/metastatic-men1-syndrome-treated-with-lutetium-177-a-case-report\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T06:59:59Z","timestamp":1764745199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.touchendocrinology.com\/metastatic-men1-syndrome-treated-with-lutetium-177-a-case-report\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"alternative-id":["EE.2019.15.2.92"],"URL":"https:\/\/doi.org\/10.17925\/ee.2019.15.2.92","relation":{},"ISSN":["1758-3772"],"issn-type":[{"type":"print","value":"1758-3772"}],"subject":[],"published":{"date-parts":[[2019]]}}}